Why AXSM? Axsome Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
AXSM
$223.70+17.17 (+8.31%)
Market ClosedLast close May 4
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.